Photo description:

JASON HALSTEAD / WINNIPEG FREE PRESS Dr. Ryan Zarychanski, a hematologist, critical-care physician, clinician-scientist and University of Manitoba professor, at work on May 6, 2020 at CancerCare Manitoba at the Health Sciences Centre. Zarychanski is responsible for including Manitoba patients in a number of COVID-19 clinical trials. He is also the principal investigator in an international clinical study that will involve 3,000 patients on a long-in-use blood-thinner medication that has shown promise treating COVID-19 patients who are sick enough to be hospitalized but not so sick that they are on ventilators. (See Martin Cash COVID-19 24-hour story)